TY  - GEN
AU  - Manning,Jessica
AU  - Vanachayangkul,Pattaraporn
AU  - Lon,Chanthap
AU  - Spring,Michele
AU  - So,Mary
AU  - Sea,Darapiseth
AU  - Se,Youry
AU  - Somethy,Sok
AU  - Phann,Sut-Thang
AU  - Chann,Soklyda
AU  - Sriwichai,Sabaithip
AU  - Buathong,Nillawan
AU  - Kuntawunginn,Worachet
AU  - Mitprasat,Mashamon
AU  - Siripokasupkul,Raveewan
AU  - Teja-Isavadharm,Paktiya
AU  - Soh,Eugene
AU  - Timmermans,Ans
AU  - Lanteri,Charlotte
AU  - Kaewkungwal,Jaranit
AU  - Auayporn,Montida
AU  - Tang,Douglas
AU  - Chour,Char Meng
AU  - Prom,Satharath
AU  - Haigney,Mark
AU  - Cantilena,Louis
AU  - Saunders,David
TI  - Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval
SN  - 1098-6596
PY  - 2015///0520
KW  - Adult
KW  - Antimalarials
KW  - administration & dosage
KW  - Arrhythmias, Cardiac
KW  - chemically induced
KW  - Artemisinins
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Malaria
KW  - drug therapy
KW  - Male
KW  - Quinolines
KW  - Young Adult
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1128/AAC.02667-14
ER  -